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Recent evidence suggests that altered expression and epigenetic modification of the glucocorticoid receptor gene (NR3C1) are related to
the risk of post-traumatic stress disorder (PTSD). The underlying mechanisms, however, remain unknown. Because glucocorticoid
receptor signaling is known to regulate emotionalmemoryprocesses, particularly inmen, epigeneticmodificationsofNR3C1might affect
the strength of traumaticmemories.Here,we found that increasedDNAmethylation at theNGFI-A (nerve growth factor-inducedprotein
A) binding site of theNR3C1 promoter was associated with less intrusivememory of the traumatic event and reduced PTSD risk inmale,
but not female survivors of the Rwandan genocide. NR3C1 methylation was not significantly related to hyperarousal or avoidance
symptoms. We further investigated the relationship between NR3C1 methylation and memory functions in a neuroimaging study in
healthy subjects. Increased NR3C1 methylation–which was associated with lower NR3C1 expression–was related to reduced picture
recognition inmale, but not female subjects. Furthermore, we foundmethylation-dependent differences in recognitionmemory-related
brain activity in men. Together, these findings indicate that an epigenetic modification of the glucocorticoid receptor gene promoter is
linked to interindividual and gender-specific differences in memory functions and PTSD risk.
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Introduction
Post-traumatic stress disorder (PTSD) is characterized by intru-
sive memories of traumatic events, avoidance, and hyperarousal
symptoms [Diagnostic and StatisticalManual ofMental Disorders,
Fourth Edition (DSM-IV), American Psychiatric Association,
2000]. In contrast to a state of chronic stress, PTSD is not paral-
leled by increased glucocorticoid levels (Meewisse et al., 2007),
but rather by enhanced hypothalamus–pituitary–adrenal (HPA)
axis feedback (Yehuda, 2002; Rohleder et al., 2004; Pitman et al.,
2012). Moreover, there is evidence suggesting that altered HPA
axis regulation and a high number of glucocorticoid receptors
(GRs) represent a pretrauma risk factor for the disorder (Yehuda,
2009; van Zuiden et al., 2011, 2013). The reason for interindi-
vidual differences in GR number and the mechanism by which
GRs influence the risk for PTSD, however, remain largely
unknown.
Timed activation of GRs is of crucial importance in memory
consolidation of learned information, especially of emotionally
arousing information (Roozendaal et al., 2006). Human studies
have shown that thememory-enhancing effects of stress-induced
elevations of glucocorticoids are usually more pronounced in
men (Andreano and Cahill, 2006; Preuss andWolf, 2009; Corne-
lisse et al., 2011). Furthermore, there is evidence that glucocorti-
coids impair the retrieval of memory processes (de Quervain et
al., 2009). Because fear learning and memory processes play an
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important role in the pathogenesis of PTSD (de Quervain, 2006;
Brewin, 2011; Pitman et al., 2012;Wilker et al., 2013),GRsmay be
implicated in PTSD risk by influencing memory processes (de
Quervain et al., 2009). Accordingly, it has been shown that the
BclI polymorphism of NR3C1 (nuclear receptor subfamily 3,
groupC,member 1), the gene encoding theGR, is associatedwith
sensitivity to glucocorticoids (van Rossum et al., 2003), emo-
tional memory in healthy individuals (Ackermann et al., 2013),
traumatic memories and PTSD symptoms in critically ill patients
(Hauer et al., 2011).
Epigeneticmechanismsmay contribute to interindividual dif-
ferences in GR signaling. DNA hypermethylation of the exon
NR3C1-17 promoter in rodents and of its human ortholog, the
exon NR3C1-1F promoter (Turner and Muller, 2005), was asso-
ciatedwith lowmaternal care,maternal depression, and perinatal
stress (Weaver et al., 2007; Oberlander et al., 2008). In line with
the enhanced GR feedback reported in PTSD cases (Yehuda,
2009), it has been shown that increased NR3C1 expression in
peripheral tissue is related to PTSD risk (van Zuiden et al., 2011).
Furthermore, it appears that these changes are partially epigeneti-
cally controlled. Two recent studies suggested that DNAmethyl-
ation of the GR gene promoter are inversely correlated with
lifetime PTSD risk (Labonte´ et al., 2014; Yehuda et al., 2014).
Moreover, allele-specific DNA demethylation of FKBP5, a regu-
lator of the GR complex, has been found to mediate gene–child-
hood trauma interactions (Klengel et al., 2013).
Given the evidence that GR signaling influences bothmemory
processes and PTSD risk, we investigated whether epigenetic dif-
ferences in the humanNR3C1 gene promoter are related to trau-
matic memory and the risk for PTSD in 152 survivors of the
Rwandan genocide. Furthermore, we investigated the relation-
ship of NR3C1 promoter DNA methylation with memory pro-
cesses in a functional neuroimaging study in 72 healthy subjects.
Materials andMethods
Subjects: Rwanda sample. We included 152 survivors from the 1994
Rwandan genocide (69 females, 83 males; median age, 35 years; range,
30–41 years) who lived as refugees in theNakivale settlement inUganda.
The sample consisted of 93 subjects fulfilling the diagnostic criteria of the
DSM-IV for lifetime PTSD, and 59 individuals who did not meet the
DSM-IV diagnostic criteria for PTSD (61.2% with PTSD lifetime diag-
nosis; 31.2% subjects with current PTSD according to DSM-IV (Ameri-
can Psychiatric Association, 2000). Additionally, to exclude genetic
relatives in the samples, only one person per household was interviewed.
Candidates exhibiting current alcohol abuse and acute psychotic symp-
toms were excluded. All subjects had experienced highly aversive trau-
matic situations and were examined in 2006/2007 (de Quervain et al.,
2007). The Post-Traumatic Diagnostic Scale (PDS; Foa et al., 1997) and
event list (Ertl et al., 2010) were administered as a structured interview by
expert psychologists from the University of Konstanz, Germany, as well
as by trained local interviewers. Interviewers first went through a six-
week course on principles of quantitative data collection and interview-
ing techniques. The translation of the instruments into Kinyarwandawas
done using several steps of translations, blind back-translations, and sub-
sequent corrections by independent groups of translators (Neuner et al.,
2008). Following the translations, the psychometric properties of the
translated scales were investigated in a validation study that included a
retest spanning a two-week period and a cross-validation with expert
rating (Neuner et al., 2008). The PDS was used to assess intrusions,
avoidance, and hyperarousal. A checklist of 36 war-related and nonwar-
related traumatic event types (e.g., injury by weapon, rape, accident) was
used to assess traumatic events (de Quervain et al., 2007; Neuner et al.,
2008). Traumatic loadwas estimated by assessing the number of different
traumatic event types experienced or witnessed. This measure is consid-
ered more reliable than assessing the frequency of traumatic events
(Neuner et al., 2008). Study procedures were approved by the ethics
committees of the University of Konstanz, Germany, and the Mbarara
University of Science and Technology, Mbarara, Uganda. Before the in-
terview, all participants provided written informed consent.
Subjects were selected to have experienced19 traumatic event types,
to avoid known ceiling effects on PTSD risk (Kolassa et al., 2010). Saliva
samples from all subjects were collected using Oragene DNA Kits (DNA
Genotek).
Subjects: Swiss sample.A total of 72 healthy young subjects (47 females,
25 males; median age, 23 years; range, 18–34 years) were included in the
functional magnetic resonance imaging (fMRI) study. fMRI data from
onemale and two female subjects were corrupted and therefore were not
included in the study. Subjects were free of any neurological or psychi-
atric illness, and did not take any medication at the time of the experi-
ment (except hormonal contraceptives). The ethics committees of the
Canton of Basel and Baselland approved the experiments.
Subjects were tested in the late morning and afternoon hours (mean
time, 2:30 P.M.; SD 3 h). All participants received general information
about the study and gave their written informed consent for participa-
tion. After completing the training outside of the scanner, subjects per-
formed two different consecutive tasks in the scanner. The first two tasks,
i.e., the picture-encoding task and the working-memory task (n-back),
were described in detail previously (de Quervain et al., 2007). Briefly,
stimuli in the picture-encoding task consisted of 72 pictures selected
from the International Affective Picture System (Lang et al., 1999) as well
as from in-house standardized picture sets that allowed us to equate the
pictures for visual complexity and content (e.g., human presence). On
the basis of normative valence scores (from1 to 9), pictureswere assigned
to emotionally negative (2.3 0.6), emotionally neutral (5.0 0.3), and
emotionally positive (7.6  0.4) conditions, resulting in 24 pictures for
each emotional valence. Four additional pictures showing neutral objects
were used to control for primacy and recency effects in memory. Two of
these pictures were presented in the beginning and two at the end of the
picture task and the working memory task. In addition, 24 scrambled
pictures were used. The background of the scrambled pictures contained
the color information of all pictures used in the experiment (except
primacy and recency pictures), overlaid with a crystal and distortion
filter (Adobe Photoshop CS3). In the foreground, a mostly transparent
geometrical object (rectangle or ellipse of different sizes and orienta-
tions) was shown. Participants were instructed and then trained on the
picture-encoding task. After training, they were positioned in the scan-
ner. The picture-encoding task, which included the arousal and valence
ratings of the pictures, lasted for20 min. Immediately afterward, sub-
jects performed the working-memory task for 10 additional minutes.
After leaving the scanner, participants gave a free recall of the pictures in
a separate room (no time limit was set for this task). Forty to 50min after
the presentation of the last picture in the encoding task, participants were
repositioned in the scanner and performed a recognition task for 20min.
The recognition task consisted of two sets of stimuli that were either new
(i.e., not presented before) or old (i.e., presented during the picture-
encoding task). Each of the two sets contained 72 pictures (24 pictures for
each emotional valence).
Using an Oragene DNA andOragene RNAKit (DNAGenotek), saliva
samples were collected from all subjects. Participants received 25 Swiss
francs per hour for participation.
DNA isolation and bisulfite conversion. Saliva DNA was initially ex-
tracted from the Oragene DNA Kit (DNA Genotek) using the precipita-
tion protocol recommended by the producer. To obtain high-purity
DNA before bisulfite conversion, samples were additionally repurified.
For this purpose, 2 g of DNA isolated via the Oragene recommended
procedure, was incubated overnight at 50°C with proteinase K (lysis
buffer: 30 mM Tris-Cl, 10 mM EDTA, 1% SDS, pH8.0, 150 ng/l
proteinase K), agitated by gentle orbital shaking. Next, the DNA was
purified using a Genomic DNA Clean & Concentrator Kit (Zymo Re-
search). The quality and concentration were assessed using gel electro-
phoresis and fluorometry (Qubit dsDNA BR Assay Kit, Invitrogen),
respectively. Five hundred nanograms of high-purity, intact DNA was
used for bisulfite conversion using an EZ DNA Methylation-Gold kit
(Zymo Research) by following standard protocols. Bisulfite DNA quality
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and concentration was determined using an RNA Pico 6000 Kit on a
Bioanalyzer 2100 instrument (Agilent Technologies) and Nanodrop
2000 (ThermoScientific). An external control sample was always con-
verted in parallel to assess possible variations in conversion reactions. All
samples were bisulfite converted on two separate occasions, under the
identical conditions. Bisulfite-converted (BSC) sampleswere normalized
to 10 ng/l.
All samples were analyzed in quadruplicates from two independent
bisulfite conversions.
Pyrosequencing analysis. The DNAmethylation status of the CpG-rich
region of the human NR3C1 gene, including the exon 1F promoter
(NR3C1-1F) with the NGFI-A binding site, previously reported as im-
portant for epigenetic regulation of GR gene expression (Weaver et al.,
2004), was quantified by direct bisulfite pyrosequencing (Tost and Gut,
2007). Primers were designed according to recommendations of Woj-
dacz et al. (2009):NR3C1_Q-CpG_FW, 5-GTTATTCGTAGGGGTATT
G-3 and NR3C1_Q-CpG_RV, 5-biot-CAACTCCCCAAAAAAAAAA
A-3 (Microsynth). A 206 bp NR3C1 promoter fragment was amplified
using an AmplyTaq Gold Kit from Applied Biosystems (Life Technolo-
gies). PCRwas done in 30l reactions containing the following: 1 PCR
buffer II, 300 M deoxynucleotide triphosphates, final 3.5 mM MgCl2,
200Mof each primer, 20 ng of BSCDNA.We used the following cycling
conditions: 95°C, 15 min–50 (95°C, 30 s; 55°C, 30 s; 72°C, 30 s)–72°C,
10min. PCR products were purified and sequenced using a PyroMark ID
System (Biotage) following the manufacturer’s suggested protocol and
two sequencing primers:NR3C1_S2, 5-GAGTGGGTTTGGAGT-3 and
NR3C1_S3, 5-AGAAAAGAAATTGGAGAAATT-3 (Microsynth) were
used as inOberlander et al. (2008). Testing for PCR temperature bias and
calibration was done by introducing a series of calibrator samples with
known methylation levels. Briefly, we prepared unmethylated standards
by using two rounds of linear whole-genome amplification with an Ova-
tion WGA System Kit (Nugene), starting from 10 ng of DNA, as recom-
mended by the manufacturer. Methylated standards were made using
CpGmethyltransferase assaywithM.SssI (NewEnglandBiolabs) starting
from 2 g of purified DNA, following the standard protocol. Bisulfite
conversion of standard samples was done as described above.
RNA isolation and expression analysis. For the purpose of DNAmethy-
lation–RNA expression correlation experiments, an additional 24 (12
females, 12males;median age, 25 years; range, 21–29 years) subjects were
recruited from the Swiss sample, as described above. RNA was isolated
from Oragene RNA Self-Collection Kits from saliva. Promptly after col-
lection, samples were mixed for 10 s by vortexing, stabilized at 50°C in a
water bath for 2.5 h, and stored at80°C until further analysis. For the
isolation procedure, samples were processed in 250 l aliquots. Briefly,
samples were incubated in a water bath at 90°C for 15 min, and then
cooled to room temperature. Following this, 750 l of TRIReagent LS
(Ambion, Life Technologies) was added to each sample and homogeni-
zation was done for 1 min at 28 Hz using TissueLyser II (Qiagen). After
homogenization, 1000 l of absolute ethanol was added to the sample
and mixed. Finally, the mixture was loaded on a Zymo-Spin IIC column
and RNA was further purified using a Direct-zol kit (ZymoResearch)
following the recommended procedure, including DNase I treatment.
The concentration and quality of the RNA was determined using Nano-
drop 2000 (ThermoScientific) and an RNA Nano 6000 Kit on a Bioana-
lyzer 2100 instrument (Agilent).
For reverse transcription, 350 ng of total RNAwas denatured for 8min
at 70°C followed by ice incubation in the presence of 25 ng of anchored
oligo(dT)20 primer (Invitrogen) and 75 ng of random decamers primers
(Ambion). In the reverse transcription reaction, cDNA was generated in
25 l reaction using a Super RT kit (HT Biotechnology). Upon comple-
tion of the reaction, the volume was adjusted to 200 l in Lambda DNA
solution (5 ng/l final concentration; Promega). The primers were de-
signed against splice variants that contain exon 1F of the NR3C1 gene:
NR3C1_1F_FW, 5-GTTGATATTCACTGATGGA-3 and NR3C1_
1F_RV, 5-CTTGGAGTCTGATTGAGA-3 (Microsynth). Additionally
total expression of the GR gene was determined against exon 2:
NR3C1_2_FW, 5-CTTCAGAACAGCAACATT-3 and NR3C1_2_RV,
5-GACTCTCATTCGTCTCTT-3 (Microsynth). The expression levels
were normalized to the RPLPO gene (human large ribosomal protein)
using the following primers: RPLP0-Ex3-4_FW, 5-CTCTGGAGAAA
CTGCTGC-3 and RPLP0-Ex3-4_RV, 5-CTGATCTCAGTGAGGTC
C-3 (Sigma-Aldrich). qPCR was performed using the Power SYBR
Green PCR Master Mix (Life Technologies) according to standard rec-
ommendations, in 12 l final volume of reaction, using 2 l of cDNA
template, on a RotorGene 6000A instrument (Corbett Research). Cy-
cling conditions were as follows: 95°C, 60 s–40 (95°C, 3 s; 56°C, 10 s;
72°C, 4 s). This was followed by amelting curve analysis (61–95°C, rising
by 0.7°C/3 s) to attest amplification specificity. Threshold cycles (cross-
ing point) were determined using Rotor-Gene software version 6.1 (Cor-
bett Research). RPLPO was selected as reference gene for normalization
after we tested several candidate reference genes, as had been previously
described (Movassagh et al., 2010). Expression levels were normalized
using a geometric mean level of expression (Vandesompele et al., 2002).
Fold differences were calculated using the delta-delta-Ct method (Pfaffl,
2001) with the help of qBasePlus software (Biogazelle).
fMRI study design. During the encoding task, the pictures were pre-
sented for 2.5 s in a quasirandomized order so that 4 pictures of the
same category occurred consecutively. A fixation cross appeared on the
screen for 500ms before each picture presentation. Trials were separated
by a variable intertrial period of 9–12 s (jitter) that was equally distrib-
uted for each stimulus category.During the intertrial period, participants
subjectively rated the picture showing scenes according to valence (neg-
ative, neutral, positive) and arousal (high, medium, and low) on a three-
point scale (self-assessment manikin) by pressing a button with a finger
of their dominant hand. For scrambled pictures, participants rated form
(vertical, symmetric, or horizontal) and size (large, medium, small) of
the geometrical object in the foreground.
During the recognition task, the pictures were presented for 1 s in a
quasirandomized order so that 4 pictures of the same category (i.e.,
negative new, negative old, neutral new, neutral old, positive new, posi-
tive old) occurred consecutively. A fixation cross appeared on the screen
for 500 ms before each picture presentation. Trials were separated by a
variable intertrial period of 6–12 s (jitter) that was equally distributed for
each stimulus category. During the intertrial period, participants subjec-
tively rated the picture as either remembered, familiar, or new on a
three-point scale by pressing a button with a finger of their dominant
hand. Recognition performance was assessed as a number of correctly
recognized previously seen pictures, corrected for the number of false
positives.
fMRI methods. Measurements were performed on a Siemens Magne-
tomVerio 3Twhole-bodyMRunit equippedwith a 12-channel head coil
(Siemens Healthcare). Functional time series were acquired with a
single-shot echo-planar sequence using parallel imaging [GRAPPA (gen-
eralized autocalibrating partially parallel acquisition)]. We used the fol-
lowing acquisition parameters: TE, 35 ms; field of view, 22 cm;
acquisitionmatrix, 80 80, interpolated to 128 128; voxel size, 2.75
2.75  4 mm3; GRAPPA acceleration factor r, 2.0. Using a midsagittal
scout image, 32 contiguous axial slices placed along the anterior–poste-
rior commissure plane covering the entire brain with a TR  3000 ms
( 82°) were acquired using an ascending interleaved sequence.
Participants received earplugs and headphones to reduce scanner
noise. The head of each participant was fixated in the coil using small
cushions, and participants were told not to move their head. Pictures
were presented in the scanner usingMR-compatible liquid crystal display
goggles (VisualSystem;NordicNeuroLab). Eye correctionwas usedwhen
necessary.
Preprocessing and data analysis was performed using SPM8 (Statisti-
cal Parametric Mapping, Wellcome Trust Centre for Neuroimaging;
http://www.fil.ion.ucl.ac.uk/spm/) implemented in Matlab R2011b
(Mathworks). Volumes were slice-time corrected to the first slice and
realigned using the “register to mean” option. A mean image was gener-
ated from the realigned series and coregistered to the structural image.
This ensured that functional and structural images were spatially aligned.
The functional images and the structural images were spatially nor-
malized by applying DARTEL (diffeomorphic anatomical registration
through exponentiated lie algebra), which leads to an improved registra-
tion between subjects. Normalization incorporated the following steps:
(1) structural images of each subject were segmented using the “New
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Segment” procedure in SPM8; (2) the resulting gray and white matter
images were used to derive a study-specific group template computed
from a large population of 612 subjects, including the 69 subjects from
this study where methylation data were available; (3) an affine transfor-
mation was applied to map the group template to MNI space; and (4)
subject-to-template and template-to-MNI transformations were com-
bined tomap the functional images toMNI space. The functional images
were smoothed with an isotropic 8 mm full width at half maximum
Gaussian filter.
Intrinsic autocorrelations were accounted for by AR(1) and low-
frequency drifts were removed via high-pass filter (time constant, 128 s).
For each subject, evoked hemodynamic responses to event types were
modeled with a delta function convolved with a canonical hemodynamic
response function within the context of a general linear model. Button
presses and rating scale presentation during ratings were modeled sepa-
rately. In addition, six movement parameters from spatial realigning
were included as regressors of no interest.
Encoding task. The effect of picture encoding was investigated by con-
structing separate regressors representing the event types for positive,
negative, neutral, and scrambled pictures. We contrasted brain activity
during the encoding of pictures against brain activity during the presen-
tation of scrambled pictures (positive, negative, and neutral pictures vs
scrambled pictures).
Recognition task. Eighteen different picture event types were modeled
by crossing each stimulus categorywith the subject-specific rating of each
picture while differentiating between correct and incorrect recognition
ratings with respect to the new or old picture set: (negative, positive,
neutral) (remembered, familiar, new) (correct, incorrect). We con-
trasted brain activity between items that were correctly recognized as
seen before and new pictures (i.e., pictures seen in the encoding task and
rated as remembered vs pictures not seen before and rated as new). Items
rated as familiar were not included in the analysis.
The contrasts of both the encoding and the recognition task were
calculated individually using a fixed-effects model (first-level analysis).
The resulting contrast parameters were then used for methylation-
dependent brain activity analyses in a random-effects, linear regression
model where we entered the methylation level as a covariate (second-
level analysis).
Construction of a population-average anatomical probabilistic atlas.Au-
tomatic segmentation of the subjects’ T1-weighted images was used to
build a population-average probabilistic anatomical atlas. More pre-
cisely, each participant’s T1-weighted image was first automatically seg-
mented into cortical and subcortical structures using FreeSurfer (Fischl
et al., 2002; version 4.5, http://surfer.nmr.mgh.harvard.edu/). Labeling
of the cortical gyri was based on the Desikan-Killiany Atlas (Desikan et
al., 2006), yielding 35 regions per hemisphere.
The segmented T1 image was then normalized to the study-specific
anatomical template space using the subject’s previously computed warp
field. After this, the image was affine-registered to the MNI space.
Nearest-neighbor interpolation was applied to preserve labeling of the
different structures. The normalized segmen-
tations were finally averaged across subjects to
create a population-average probabilistic atlas.
Each voxel of the template could consequently
be assigned a probability of belonging to a
given anatomical structure, based on the indi-
vidual information from all subjects.
Statistical analyses. Statistical analyses were
done in R (version 12.15.2; R Development
Core Team 2012). Due to non-normal distri-
bution ofmethylation data in theRwanda sam-
ple, we applied nonparametric tests. We
assessed DNA methylation, trauma load, and
age differences between two genders by
Kruskal–Wallis one-way ANOVA and correla-
tions of DNA methylation data with PTSD
symptom clusters scores by Spearman’s rank
correlation (s). To account for trauma load
and ceiling effects (Kolassa et al., 2010), PTSD
symptom cluster scores were divided by the
sum of lifetime traumatic event types (i.e., symptoms scores per trau-
matic event type; de Quervain et al., 2007). The relationship between
DNA methylation at NR3C1 promoter and lifetime PTSD status was
assessed using binary logistic regression, withNR3C1 CpG3 DNAmeth-
ylation as quantitative predictor and the sumof life traumatic event types
as a covariate.
Due to normal distribution of themethylation data, statistical analyses
of behavioral data for the Swiss sample were performed using linear
models. The relationship of NR3C1 DNA methylation to memory per-
formance and NR3C1 expression was assessed using linear models. To
account for methylation-dependent differences in arousal during recog-
nition of previously seen pictures, both arousal and NR3C1 CpG3 DNA
methylation were included in the linear model: we modeled valence-
specific recognition performance as dependent on NR3C1 CpG3 DNA
methylation and valence-specific arousal.
Correlation betweenNR3C1 CpG3 DNAmethylation andNR3C1 ex-
pression was examined by linear regression model, corrected for age
independently in two genders.
A comparison of methylation levels of NR3C1 CpG3 site between the
Rwandan and the Swiss populationwas done byKruskal–Wallis one-way
ANOVA. Furthermore, we additionally assessed the equality of distribu-
tions and variability between two populations: Kolmogorov–Smirnov
two-sample test and Siegel–Tukey test, respectively.
Bonferroni correction was implemented to account for multiple test-
ing procedures. The significance threshold was set to p 0.05.
All laboratory procedures were conducted in a blind, randomized or-
der, including DNA and RNA isolations, bisulfite conversion, PCR, py-
rosequencing, and expression analysis. Only after performing all
procedures and excluding samples with low quality controls and outliers,
further analysis with phenotypic data was performed.
Results
DNAmethylation of the NR3C1 promoter in traumatized
survivors of the Rwandan genocide
The promoter region of the NR3C1 gene studied herein is illus-
trated in Figure 1. It spans the exon 1F region, a human ortho-
logue of the rat exon 1-7 (Turner and Muller, 2005), previously
reported as differentially methylated (Oberlander et al., 2008;
McGowan et al., 2009). The analysis covered eight CpGs, with the
NGFI-A consensus binding sequence encompassing CpG posi-
tions 3 and 4. Because glucocorticoid-related changes inmemory
formation were repeatedly found to bemore pronounced inmen
(Andreano and Cahill, 2006; Preuss and Wolf, 2009), we also
considered possible gender differences in the present study. We
first compared DNA methylation between genders and found
significant differences between men and women at several CpG
positions (p  0.05, e.g., methylation levels at NR3C1_CpG3
1B 1F 1G 1C  2 3‘5‘
+1
                                                                         1  2                      3              
  -3236 ttgccgccaaggggcagagcgagctcccgagtgggtctggagccgcggagctgggcggggg-
   4                                     5                                                                  6                                     7        8
  cgggaaggAGGTAGCGAGAAAAGAAACTGGAGAAACTCGGTGGCCCTCTTAACGCC-
  -3225 GCCCCAGAGAG
Figure 1. Human NR3C1 gene and the CpG region analyzed by bisulfite pyrosequencing. The 5 region of the NR3C1 gene
contains multiple first exons, corresponding to multiple transcriptional start sites and multiple mRNA splice variants. The region
analyzedbypyrosequencing is illustratedbyenlargedbox, below theexon1F.Numbering is relative to thealternative transcription
start site in exon 2. The CpG3 and CpG4 sites are encompassed by the potential NGFI-A binding site. Adapted fromOberlander et al.
(2008).
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were significantly higher in women than
in men, p  0.01). Therefore, we pro-
ceeded with gender-specific analyses. To
account for trauma load, PTSD symptom
cluster scores were corrected by the sum
of lifetime traumatic event types (de
Quervain et al., 2007). Methylation levels
at theCpG3 site, which is embedded in the
NGFI-A consensus binding sequence,
were significantly negatively correlated
with the severity of symptoms related to
re-experiencing traumatic events (intru-
sive memories) in men (s  0.355,
pnominal 0.001, pBonferroni corrected 0.008
for eight CpG comparisons; Fig. 2, Table
1). No such association was found in
women (s  0.073, pnominal  0.553;
Table 2). Correlations of DNA methyl-
ation at CpG3 with the severity of
symptoms related to avoidance and hy-
perarousal were not significant after Bon-
ferroni correction for eight CpGs (p 
0.05), indicating that the methylation
changes at this site were preferentially re-
lated to the memory aspects of PTSD.
None of the other examined NR3C1 pro-
moter CpG sites were significantly associ-
ated with any of the PTSD symptom
scores, after accounting for multiple test-
ing (Tables 1, 2), indicating a pronounced
role of methylation at the CpG3 site.
Furthermore, we investigated whether
methylation levels at CpG3 were signifi-
cantly associated with lifetime PTSD risk
(taking into account the total number of
experienced traumatic event types; see
Materials and Methods). We found that
higher methylation levels were signifi-
cantly associated with a lower lifetime
PTSD risk in men (binary logistic regres-
sion model, 0.519, Wald 2 7.0,
p 0.008; Fig. 3), but not in women (
0.170,Wald 2 1.4, p 0.243; Fig. 3).
Interindividual differences in methyl-
ation levels at CpG3were not significantly
associated with the number of traumatic
life event types (p  0.23 and 0.76 for
men and women, respectively). Further-
more, age was not significantly associ-
ated with DNA methylation in either
gender (p  0.10 and 0.14 for men and
women, respectively).
DNAmethylation at the NR3C1
promoter, memory performance,
and fMRI activity during picture
recognition
Because in genocide survivors NR3C1
CpG3 methylation was strongly associ-
ated with the intrusive memory aspect of
PTSD and given the role of glucocorticoid
signaling in memory processes (de Quer-
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Figure 2. DNAmethylation of NR3C1 promoter and PTSD symptoms in male genocide survivors. Association (Spearman’s rank
correlation, log10p) of DNA methylation marks across eight CpG positions in the human NR3C1 gene promoter with PTSD
symptoms clusters intrusions, avoidance, and hyperarousal. The association between CpG3 and intrusions reached Bonferroni-
corrected statistical significance (after correcting for 8 tests; PBonferroni 0.008). The CpGs are aligned by genomic position. The
position of the potential NGFI-A binding site is shaded in purple. The horizontal dashed line indicates the p 0.05 Bonferroni-
corrected significance threshold.
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relationship of NR3C1 DNA methylation variation to memory
processes in healthy humans. Specifically, we investigated
whether NR3C1 CpG3 methylation levels in healthy individuals
were associated with memory performance and brain activation
during a picture-recognition task in the fMRI scanner.
NR3C1 CpG3 DNA methylation was negatively correlated
with the correct recognition of previously seen pictures in men
but not in women (men:   0.455, p  0.012; women:  
0.065, p 0.667; Table 3). Furthermore, DNA methylation at
this site in men was significantly associated with arousal during
encoding of negative pictures, but not of neutral or positive pic-
tures (Table 3). After correcting for the valence-specific arousal
rating, recognition of previously seen pictures was significantly
negatively correlated withNR3C1CpG3 DNAmethylation inde-
pendently of the valence category in men but not in women (Ta-
ble 3). Free-recall performance was not related to methylation
levels atNR3C1CpG3 (men: 0.291, p 0.16; women: 
0.048, p 0.74).
Next, we performed a methylation-dependent fMRI analysis
during successful memory recognition (see Materials and Meth-
ods). In men, we found a whole-brain, family-wise error (FWE)
multiple-comparison corrected (pFWE corrected  0.05, puncorrected
 0.001) positive correlation between methylation levels at the
CpG3 site of the NR3C1 promoter and brain activity related to
the successful recognition of previously seen pictures in the pars
triangularis and pars orbitalis of the inferior frontal gyrus, in the
cuneus, and in the vicinity of the superior temporal and superior
frontal cortices (Fig. 4, Table 4). No voxels correlated signifi-
cantly with methylation values in the opposite direction. We did
not observe significant associations betweenmethylation levels at
the CpG3 site and brain activity in females. Moreover, we did not
find significant correlations of individual methylation levels with
encoding-related brain activity.
Finally, we compared methylation levels of NR3C1 promoter
CpG3 site between the Rwandan and the Swiss sample. Impor-
tantly, we did not find a significant difference in median,
distribution, or variability between the samples (Kruskal–Wallis
2 1.392, p 0.24; Kolmogorov–SmirnovD 0.150, p 0.22;
Siegel–TukeyW 4829.5, p 0.29). These findings suggest that
methylation at this specific site is a stable trait and likely pre-
existed the traumatic event in the Rwandan population.
Expression of the GR gene and DNAmethylation at the
NR3C1 gene promoter
Finally, we tested whether DNAmethylation on the CpG3 site of
theNR3C1promoterwas associatedwithNR3C1 gene expression
in a subset of 24 healthy (12 females and 12males) subjects. DNA
methylation at the CpG3 site correlated significantly with both
Table 1. Association of PTSD symptom clusters and DNAmethylation of NR3C1 gene promoter in Rwandanmena
PTSD symptom clusters (nmales 83) NR3C1_CpG1 NR3C1_CpG2 NR3C1_CpG3 NR3C1_CpG4 NR3C1_CpG5 NR3C1_CpG6 NR3C1_CpG7 NR3C1 _CpG8
Intrusionsb
Spearman’s  0.235 0.039 0.355 0.128 0.203 0.059 0.118 0.18
p value
Nominal 0.037* 0.733 0.001*** 0.261 0.073 0.606 0.3 0.112
Bonferroni correction for 8 CpGs 0.296 1 0.008 1 0.584 1 1 0.896
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 0.048 1 1 1 1 1
Avoidanceb
Spearman’s  0.115 0.033 0.260 0.033 0.101 0.049 0.019 0.074
p value
Nominal 0.315 0.772 0.021* 0.77 0.376 0.666 0.87 0.517
Bonferroni correction for 8 CpGs 1 1 0.168 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 1 1 1 1 1 1
Hyperarousalb
Spearman’s  0.187 0.097 0.346 0.038 0.165 0.074 0.08 0.053
p value
Nominal 0.099 0.396 0.009** 0.74 0.145 0.514 0.483 0.645
Bonferroni correction for 8 CpGs 0.792 1 0.072 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 0.432 1 1 1 1 1
PDS scoreb,c
Spearman’s  0.207 0.056 0.355 0.081 0.172 0.036 0.078 0.112
p value
Nominal 0.067 0.627 0.001*** 0.476 0.131 0.756 0.496 0.324
Bonferroni correction for 8 CpGs 0.536 1 0.008 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 0.048 1 1 1 1 1
NR3C1 DNAmethylation
Mean 2.86 1.52 2.84 1.01 1.77 3.52 4.88 1.83
SD 1.32 1.55 1.56 1.45 1.58 1.81 1.82 1.56
aCorrelation of NR3C1 gene promoter DNAmethylation with sum of PTSD-specific symptom subscores according to PDS and DSM-IV. To account for trauma load, PTSD symptom cluster scores were divided by the sum of lifetime traumatic
event types. Spearman’s correlation s coefficients and the corresponding nominal and Bonferroni-corrected p values are shown for each symptom cluster.
bSum of specific symptom clusters corrected for total number of lifetime traumatic events.
cPDS score is not an additional symptommeasure, as it represents the sum of the subscores of Intrusions, Avoidance, and Hyperarousal.
***Correlation is nominally significant at the 0.001 level (2-tailed, Spearman’s ).
**Correlation is nominally significant at the 0.01 level (2-tailed, Spearman’s ).
*Correlation is nominally significant at the 0.05 level (2-tailed, Spearman’s ).
Vukojevic et al. • DNA-Methylation of Nr3c1 Is Linked to PTSD and Memory J. Neurosci., July 30, 2014 • 34(31):10274–10284 • 10279
























Figure 3. Fitted values of probability for lifetime PTSD risk against DNA methylation at the NGFI-A binding site of the NR3C1 promoter for males and females. Lifetime PTSD risk was assessed
against NR3C1 CpG3 DNA methylation and the number of lifetime traumatic event types via binary logistic regression (nmales 83, pnominal_males 0.008, males0.519; nfemales 69,
pnominal_females 0.243,females0.170). This graph also contains the raw CpGmethylation values obtained in participants without (bottom line) and with (top line) PTSD.
Table 2. Association of PTSD symptom clusters and DNAmethylation of NR3C1 gene promoter in Rwandanwomena
PTSD symptom clusters (nfemales 69) NR3C1_CpG1 NR3C1_CpG2 NR3C1_CpG3 NR3C1_CpG4 NR3C1_CpG5 NR3C1_CpG6 NR3C1_CpG7 NR3C1_CpG8
Intrusionsb
Spearman’s  0.166 0.013 0.073 0.037 0.065 0.033 0.071 0.019
p value
Nominal 0.173 0.916 0.553 0.763 0.598 0.785 0.561 0.876
Bonferroni correction for 8 CpGs 1 1 1 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 1 1 1 1 1 1
Avoidanceb
Spearman’s  0.116 0.118 0.139 0.006 0.059 0.058 0.045 0.092
p value
P-value (nominal) 0.344 0.333 0.256 0.963 0.633 0.635 0.714 0.45
Bonferroni correction for 8 CpGs 1 1 1 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 1 1 1 1 1 1
Hyperarousalb
Spearman’s  0.003 0.014 0.052 0.053 0.002 0.04 0.057 0.033
p value
Nominal 0.983 0.912 0.672 0.667 0.99 0.746 0.642 0.79
Bonferroni correction for 8 CpGs 1 1 1 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 1 1 1 1 1 1
PDS scoreb,c
Spearman’s  0.114 0.046 0.089 0.011 0.003 0.006 0.063 0.054
p value
Nominal 0.352 0.706 0.469 0.928 0.982 0.959 0.605 0.657
Bonferroni correction for 8 CpGs 1 1 1 1 1 1 1 1
Bonferroni correction for 8 CpGs, sex,
and 3 PTSD symptom clusters
1 1 1 1 1 1 1 1
NR3C1 DNAmethylation
Mean 3.23 1.90 3.55 1.10 2.42 4.16 5.43 2.29
SD 1.62 1.81 1.85 1.59 1.83 2.32 1.96 1.90
aCorrelation of NR3C1 gene promoter DNAmethylation with sum of PTSD-specific symptom subscores according to PDS and DSM-IV. To account for trauma load, PTSD symptom cluster scores were divided by the sum of lifetime traumatic
event types. Spearman’s correlation  coefficients and the corresponding nominal and Bonferroni-corrected p values are shown for each symptom cluster.
bSum of specific symptom clusters corrected for total number of traumatic events in a lifetime.
cPDS score is not an additional symptommeasure, as it represents the sum of the subscores of Intrusions, Avoidance and Hyperarousal.
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exon 1F and totalNR3C1 expression (0.812, p 0.001 and
0.759, p 0.003, respectively; in both males and females,
p 0.05). Thus, DNAmethylation at theNGFI-A transcriptional
factor-binding site of NR3C1 correlated negatively with NR3C1
expression in saliva.
Discussion
The present study indicates that DNAmethylation at theNR3C1
exon 1F promoter is linked to traumaticmemories and PTSD risk
in male, but not in female genocide survivors. These methylation
differences are located at theNGFI-A transcriptional factor bind-
ing sequence and the methylation levels correlated negatively
with the expression of NR3C1, indicating the functional rele-
vance of the methylation status at this site.
Studies in rodents have shown that specific 5NR3C1-17 pro-
moter sites are targets ofDNAmethylation, leading to suppressed
NGFI-A binding and consequently decreased NR3C1 gene ex-
pression (Weaver et al., 2007). DNA hypermethylation at these
sites has been associated with low quality of received maternal
care in adultmale offspring (female offspringwere not examined;
Weaver et al., 2004), as well as prenatal stress exposure (Mueller
and Bale, 2008). Hypermethylation at the human ortholog
NR3C1-1F promoterNGFI-A binding site was likewise associated
to perinatal stress and maternal depression (Oberlander et al.,
2008). A recent study inmale combat veterans reported thatDNA
methylation atNR3C1-1F in peripheral blood mononuclear cells
was inversely correlated with PTSD risk,NR3C1 gene expression,
cortisol decline in response to dexamethasone, and clinical mea-
sures of PTSD, including poorer sleep (Yehuda et al., 2014). An-
other study reported that DNA methylation of NR3C1-1B and
NR3C1-1C promoters in sorted T-lymphocytes is also inversely
correlated with PTSD risk andmorning cortisol levels in individ-
uals with different trauma background (Labonte´ et al., 2014).
Epigenetic marks at theNR3C1 locus are set during a sensitive
period around birth and seem to remain stable throughout life in
rodents (Weaver et al., 2004; Mueller and Bale, 2008; Suderman
et al., 2012) and humans (Oberlander et al., 2008; McGowan et
al., 2009; Radtke et al., 2011; Suderman et al., 2012). These find-
ings suggest that, in the present study, NR3C1 methylation dif-
ferences may have existed before the traumatic events.
Alternatively, trauma exposure might have triggered mecha-
nisms that lead to altered epigenetic patterns. In the present
study, interindividual differences in methylation levels at the
NR3C1-1Fpromoterwere not related to traumatic load. Likewise,
Yehuda et al. also reported no significant association between
trauma exposure and NR3C1-1F promoter DNA methylation
(Yehuda et al., 2014). Furthermore, we did not observe signifi-
cant differences in medians and interindividual variability of
NR3C1-1F promoter methylation between Rwandan genocide
survivors and healthy individuals not exposed to trauma. To-
gether, these findings suggest that the differences in methylation
levels pre-existed the traumatic events, supporting the idea that
alterations in theHPA axis regulation represent at least partially a
pretrauma risk factor for the disorder (Yehuda, 2009; de Quer-
vain et al., 2009). Pre-existing differences in DNAmethylation at
NR3C1may be a result of interplay between selected types of early
adversity and specific timing of exposure. They may also reflect
other types of risks associated with the HPA axis inhibition (Ye-
huda, 2009). Finally, one possibility is that NR3C1-1F promoter
DNA methylation differences are a result of development/early
life-associated stochastic epigenetic variation leading to differ-
ences in disease susceptibility (Feinberg and Irizarry, 2010).
Characterization of the causal pathways involved in epigenetic
modifications and the relative stability and reversibility of such
Figure 4. Methylation-dependent differences in brain activity related to successful recogni-
tion of previously seen pictures in healthymen. Displayed are voxels with a positive correlation
betweenmethylation values (atNR3C1_CpG3) andactivity, using color-coded t values. Theblue
circles show the activation in the pars triangularis and pars orbitalis of the inferior frontal gyrus
(centered at 44, 25,4; peakpFWE corrected0.05; displayed atpuncorrected0.001; a random-
effects, linear-regression model). Activations are overlaid on coronal (upper left), sagittal (up-
per right), and axial sections of the study-specific group template (seemain text). L, Left side of
the brain; R, right side of the brain.
Table 3. NR3C1 CpG3 DNAmethylation and recognition performance in the Swiss
samplea
NR3C1 CpG3
Women (nfemales 47) Men (nmales 25)
Recognition of all pictures
 0.065 0.455
p value 0.667 0.012*
Arousal for positive pictures
 0.148 0.343
p value 0.320 0.094
Arousal for negative pictures
 0.009 0.431
p value 0.954 0.031*
Arousal for neutral pictures
 0.135 0.266
p value 0.366 0.199
Recognition of positive pictures corrected for
arousal
 0.036 0.447
p value 0.817 0.041*
Recognition of negative pictures corrected
for arousal
 0.289 0.481
p value 0.050* 0.010**
Recognition of neutral pictures corrected for
arousal
 0.014 0.643
p value 0.927 0.002**
aRecognition corrected for arousal. To account formethylation-dependent differences in arousal during recognition
of previously seen pictures, both arousal and NR3C1 CpG3 DNA methylation were included in the linear model. We
modeled valence-specific recognition performance as dependent on NR3C1 DNA methylation and valence-specific
arousal. Coefficients and the corresponding p values are shown for each recognition and arousal category (DNA
methylation mean SD:NR3C1 CpG3 Females 3.20 1.29,NR3C1 CpG3 Males 3.28 1.21).
**Correlation is significant at the 0.01 level.
*Correlation is significant at the 0.05 level.
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changes require more research (Zhang et al., 2010; Hunter and
McEwen, 2013).
Previous studies investigated epigenetic modifications associ-
atedwith PTSD in peripheral blood (Chang et al., 2012; Klengel et
al., 2013; Mehta et al., 2013; Labonte´ et al., 2014; Yehuda et al.,
2014). In this studywe usedDNA isolated from saliva. The source
of DNA in saliva is a mixture of ectodermal-origin epithelial cells
and white blood cells (Zhou et al., 2011). Several studies suggest
that DNA methylation signatures in genomic regions rich in
cytosine-guanine dinucleotides (as it is the casewithNR3C1-1Fpro-
moter) generally show stable epigenetic signatures across brain
and nonbrain tissues (Ladd-Acosta et al., 2007; Mill et al., 2008;
Lister et al., 2009; Dempster et al., 2011; Davies et al., 2012).
Indeed, it has been shown that childhood adversity is related to
NR3C1-1F promoter methylation both in peripheral tissue
(Oberlander et al., 2008; Radtke et al., 2011) and in the brain
(McGowan et al., 2009). Moreover, we have found that interin-
dividual differences inmethylation of theNR3C1-1F promoter in
DNA isolated from saliva were associated with differences in
brain activity. Together, these findings suggest that with regard to
NR3C1-1F methylation, similar patterns may be present across
tissues. Thus, it may be possible to a certain extent to use non-
brain tissue for the investigation of certain CNS traits, such as
psychiatric disorders.
As expected, we found that increased DNAmethylation at the
NR3C1-1F promoter negatively correlated with expression of
NR3C1. It is known that an acute and timed activation of GRs is
crucially involved in memory formation (Roozendaal, 2000;
Roozendaal et al., 2006). Thus, increasedNR3C1promotermeth-
ylation might be related to reduced memory formation, includ-
ing traumatic memory after a traumatic event. Indeed, we found
that increased NR3C1-1F CpG3 methylation was associated with
less intrusive memory (genocide survivors) and less picture-
recognitionmemory (healthy population), but only inmales. It is
unlikely that gender differences inmethylation or expressionmay
have accounted for the lack of relationship between methylation
and memory in women, because the correlation between CpG3
methylation and NR3C1 expression was independent of gender.
We hypothesize that the gender-specific findings reported herein
occur post-transcriptionally, possibly reflecting gender-specific
effects of glucocorticoids on memory. Indeed, the finding that
NR3C1-1F methylation was related to memory only in men is in
line with reports that found glucocorticoid effects on memory to
bemore pronounced inmen than inwomen, or even restricted to
men (Andreano and Cahill, 2006; Preuss andWolf, 2009; Corne-
lisse et al., 2011). The reason for this gender-dependent differ-
ence in glucocorticoid effects is not well understood. A possible
interaction between glucocorticoids and sex hormones has been
proposed (Preuss andWolf, 2009), and further efforts are neces-
sary to address sex-related differences in glucocorticoid signaling
and its molecular signatures.
The present findings point to a relationship ofNR3C1-1F pro-
moter methylation with memory processes also in healthy hu-
mans. Specifically, we found that methylation levels at the
NR3C1-1F correlated negatively with recognition memory in
men, but not in women. This relationship was independent of
valence, which is in line with previous findings indicating that the
memory-modulating effects of elevated glucocorticoid levels can
also affect neutral material when the learning context is emotion-
ally arousing (Preuss and Wolf, 2009). The neuroimaging find-
ings indicated that male subjects with higher methylation levels
had increased activation in the right ventrolateral prefrontal cor-
tex (VLPFC) and the cuneus. Interestingly, the right VLPFC has
been discussed as a brain region involved in retrieval attempt and
effort rather than retrieval success (Taylor et al., 2004; Badre and
Wagner, 2007), which is in line with the present finding of
increased activation in this region in subjects with higher meth-
ylation levels and less successful recognition performance.More-
over, a recent meta-analysis has pointed to an involvement of the
VLPFC in the neurocircuitry of PTSD (Hayes et al., 2012). Spe-
cifically, patients with PTSD show decreased activity in the infe-
rior frontal gyrus compared with trauma-exposed controls
without PTSD when reliving one’s traumatic event.
The relationship between glucocorticoids, memory, and
PTSD is complex and not fully understood. Whereas high num-
bers of GRs before trauma have been found to be a risk factor for
developing PTSD (van Zuiden et al., 2011), a pharmacological
elevation of glucocorticoid levels during or after a traumatic
event seems to prevent and reduce PTSD symptoms (Schelling et
al., 2001, 2004; Aerni et al., 2004). This may have to do with
differential effects of glucocorticoids depending on timing and
the memory phase affected (de Quervain et al., 2009; Joe¨ls et al.,
2011). A timed activation of GRs is important for memory con-
solidation and may lead to strong aversive memories in case of a
traumatic event. On the other hand, elevated glucocorticoid lev-
els have been shown to impair memory retrieval of emotionally
arousing information, which may lead to reduced traumatic
memories (de Quervain et al., 2009). In addition to the glucocor-
ticoid effects on emotional memory, evidence indicates that glu-
cocorticoids can have effects on emotional processing: a recent
study suggested that the presence of elevated levels of glucocor-
ticoids at the time of acute stress confers protection against the
delayed enhancing effect of stress on amygdala synaptic connec-
tivity and anxiety-like behavior (Rao et al., 2012). Thus, altered
glucocorticoid signaling may have differential effects on the de-
velopment and symptoms of PTSD, depending on the emotional
and cognitive processes affected.
In conclusion, we provide evidence that DNA methylation at
the NR3C1-1F promoter is preferentially related to the memory
aspects of PTSD symptomatology and PTSD risk in men. More-
over, we found that the same epigenetic modification was related
to memory functions in healthy subjects, suggesting that this
Table 4. Methylation-dependent differences in brain activity related to the successful recognition of previously seen pictures in healthymale individualsa
Maximum t value within cluster Regional correspondence of the maximum
MNI coordinates at maximum
X Y Z
6.4174 Cortex-right hemisphere-pars orbitalis (36%),
cortex-right hemisphere-pars triangularis
(31%) of the inferior frontal gyrus
44 24.75 4
6.5307 Near superior temporal cortex 44 16.5 16
6.3278 Cortex-left hemisphere-cuneus (48%), cortex-left
hemisphere-pericalcarine (10%)
0 85.25 12
6.4978 Near superior frontal cortex 19.25 38.5 32
apFWE whole-brain corrected 0.05. Swiss sample, nmales 24. Regions and probabilities in accordance to the in-house atlas (see Materials and Methods).
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modification possibly affects traumatic memory and PTSD via a
modulation of memory processes. The present findings may add
to the understanding of individual PTSD risk factors and suggest
thatNR3C1DNAmethylationmay represent a biological marker
for traumatic memories and PTSD.
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